All tumors expressed some level of OCT1, with most (35 of 39) exhibiting an Allred score of 5 or higher (Figure 4A and 4B), indicating the potential for metformin uptake by tumor cells and sensitivity to the direct effects of the drug. Here, SLC22A1 is linked to neoplasm.